Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.
Hilo has raised $42.0M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Hilo's investors include Khosla Ventures, Earlybird Venture Capital, K Fund, Wellington Partners, Verve Ventures.
Hilo is headquartered in Neuchâtel, Switzerland.
Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.
Hilo is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hilo — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/hilo-neuchtel. Accessed July 19, 2026.
VCBacked. (2025). Hilo — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hilo-neuchtel
{{cite web |title=Hilo — Funding & Investors |url=https://www.vcbacked.co/company/hilo-neuchtel |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated